Kyntra Bio, Inc. (KYNB)
7.00
-0.25
(-3.45%)
USD |
NASDAQ |
Sep 24, 16:00
7.29
+0.29
(+4.14%)
Pre-Market: 08:00
Kyntra Bio Gross Profit (Annual) : 5.136M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 5.136M |
| December 31, 2024 | 14.06M |
| December 31, 2023 | 36.22M |
| December 31, 2022 | 120.45M |
| December 31, 2021 | 207.63M |
| December 31, 2020 | 145.40M |
| December 31, 2019 | 233.98M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Vericel Corp. | 205.60M |
| Capricor Therapeutics, Inc. | -1.890M |
| ARS Pharmaceuticals, Inc. | 63.86M |
| ACADIA Pharmaceuticals, Inc. | 971.62M |
| Alnylam Pharmaceuticals, Inc. | 3.032B |